Raab & Moskowitz Asset Management’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History
Bought
Maintained
Sold
Other funds holding AUXL
Raab & Moskowitz Asset Management's AUXL Position: Q1 2015 in Review
Raab & Moskowitz Asset Management sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 200 shares — an estimated $7K sold.
Raab & Moskowitz Asset Management first reported a position in AUXL in Q4 2014 and held it in 1 quarter. The position peaked at $7K in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.
- Raab & Moskowitz Asset Management reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
- Raab & Moskowitz Asset Management sold 200 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $7K.
- Raab & Moskowitz Asset Management first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q4 2014 and held it in 1 quarter.
- Raab & Moskowitz Asset Management's AUXILIUM PHARAMCEUTICALS INC position peaked at $7K in Q4 2014.
- 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.
Based on Raab & Moskowitz Asset Management's 13F filing for Q1 2015, filed 12 May 2015.